Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Frontiers in Bioscience (Landmark Edition)
|
March 11, 2009
PML links aberrant cytokine signaling and oncogenic stress to cellular senescence
Veronique Bourdeau, David Baudry, Gerardo Ferbeyre
The British Journal of Dermatology
|
July 17, 2025
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking in palmoplantar pustulosis
Alice Smail, Nick Dand, Xinyue Liu, et al.
The Journal of Investigative Dermatology
|
August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study
Nina Wilkinson, Teresa Tsakok, Nick Dand, et al.
The Journal of Investigative Dermatology
|
February 21, 2025
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard
Charlotte M Thomas, David Baudry, Zehra Arkir, et al.
The Journal of Investigative Dermatology
|
February 21, 2025
Genetic Risk Factors in Childhood Psoriasis
Christopher Willy Schwarz, Christoffer Blegvad, David Baudry, et al.
British Journal of Clinical Pharmacology
|
February 15, 2026
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data
Charlotte M Thomas, Jessica Ruoheng Wei, David Baudry, et al.
The Journal of Investigative Dermatology
|
April 14, 2020
Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study
Floris C Loeff, Teresa Tsakok, Lisanne Dijk, et al.
The Lancet. Rheumatology
|
November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
Satveer K Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet. Rheumatology
|
July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Satveer K Mahil, Katie Bechman, Antony Raharja, et al.
Nature Communications
|
December 14, 2018
Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne
Christos Petridis, Alexander A Navarini, Nick Dand, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Frontiers in Bioscience (Landmark Edition)
|
March 11, 2009
PML links aberrant cytokine signaling and oncogenic stress to cellular senescence
Veronique Bourdeau, David Baudry, Gerardo Ferbeyre
The British Journal of Dermatology
|
July 17, 2025
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking in palmoplantar pustulosis
Alice Smail, Nick Dand, Xinyue Liu, et al.
The Journal of Investigative Dermatology
|
August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study
Nina Wilkinson, Teresa Tsakok, Nick Dand, et al.
The Journal of Investigative Dermatology
|
February 21, 2025
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard
Charlotte M Thomas, David Baudry, Zehra Arkir, et al.
The Journal of Investigative Dermatology
|
February 21, 2025
Genetic Risk Factors in Childhood Psoriasis
Christopher Willy Schwarz, Christoffer Blegvad, David Baudry, et al.
British Journal of Clinical Pharmacology
|
February 15, 2026
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world data
Charlotte M Thomas, Jessica Ruoheng Wei, David Baudry, et al.
The Journal of Investigative Dermatology
|
April 14, 2020
Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study
Floris C Loeff, Teresa Tsakok, Lisanne Dijk, et al.
The Lancet. Rheumatology
|
November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
Satveer K Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet. Rheumatology
|
July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Satveer K Mahil, Katie Bechman, Antony Raharja, et al.
Nature Communications
|
December 14, 2018
Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne
Christos Petridis, Alexander A Navarini, Nick Dand, et al.
Page
of 3